Meditoxin 200U

Botulinum A, known as Meditoxin 200U, was developed by Medy Tox Korea Limited and received approval from the KDA in 2004, demonstrating superiority over Botox.

The effects of Meditoxin treatment persist for 4-6 months, necessitating subsequent treatments for sustained results. When administered correctly, negative side effects are minimal, aligning with recommended usage.

However, improper application can lead to adverse reactions, akin to any botulinum toxin. Utilizing botulinum toxin for unintended purposes poses heightened risks, potentially causing the weakening of facial muscles.

Meditoxin finds application in the following scenarios:

• Addressing hyperhidrosis
• Managing bruxism
• Mimicking forehead lines and crow's feet

Meditoxin 200U Description:

Available in a transparent vial as lyophilized white powder for injection, Meditoxin's efficacy is comparable to Botox (Allergan).

The powder is compacted within a glass ampoule included in the packaging, which may occasionally seem empty. To use, combine saline with the powder in the ampoule, with recommended proportions of 2.5 ml for 100 units and 5 ml for 200 units.

Strictly intended for use by professionals, purchasers confirm their status as medical professionals with training in aesthetic medicine when making a purchase.